{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:32:11Z","timestamp":1793935931269,"version":"4.8.0"},"reference-count":173,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10142-025-01579-0","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T14:53:37Z","timestamp":1743087217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cutting edge: ferroptosis in metabolic dysfunction-associated steatotic liver disease (MASLD) pathogenesis and therapy"],"prefix":"10.1007","volume":"25","author":[{"given":"Amr Ali Mohamed Abdelgawwad","family":"El-Sehrawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teeba Ammar","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9316-0967","authenticated-orcid":false,"given":"Muhammad Ikram","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subasini","family":"Uthirapathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subbulakshmi","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhayveer","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Devi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal Kant","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Salman","family":"Jasim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abed J.","family":"Kadhim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"1579_CR1","doi-asserted-by":"crossref","unstructured":"Aschemeyer S, Qiao B, Stefanova D, Valore EV, Sek AC, Ruwe TA, Vieth KR, Jung G, Casu C, Rivella S (2018) 'Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin'. Blood J Am Soc Hematol 131:899\u2013910","DOI":"10.1182\/blood-2017-05-786590"},{"key":"1579_CR2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2337\/db20-0884","volume":"70","author":"RK Baboota","year":"2021","unstructured":"Baboota RK, Bl\u00fcher M, Smith U (2021) Emerging role of bone morphogenetic protein 4 in metabolic disorders. Diabetes 70:303\u2013312","journal-title":"Diabetes"},{"key":"1579_CR3","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-230X-10-98","volume":"10","author":"G Bedogni","year":"2010","unstructured":"Bedogni G, Kahn HS, Bellentani S, Tiribelli C (2010) A simple index of lipid overaccumulation is a good marker of liver steatosis. BMC Gastroenterol 10:98","journal-title":"BMC Gastroenterol"},{"key":"1579_CR4","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, Roberts MA, Tong B, Maimone TJ, Zoncu R, Bassik MC, Nomura DK, Dixon SJ, Olzmann JA (2019) The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 575:688\u2013692","journal-title":"Nature"},{"key":"1579_CR5","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41586-020-2668-z","volume":"586","author":"CB Billesb\u00f8lle","year":"2020","unstructured":"Billesb\u00f8lle CB, Azumaya CM, Kretsch RC, Powers AS, Gonen S, Schneider S, Arvedson T, Dror RO, Cheng Y, Manglik A (2020) Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms. Nature 586:807\u2013811","journal-title":"Nature"},{"key":"1579_CR6","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.3390\/antiox13111363","volume":"13","author":"JL Bucarey","year":"2024","unstructured":"Bucarey JL, Trujillo-Gonz\u00e1lez I, Paules EM, Espinosa A (2024) Myokines and Their Potential Protective Role Against Oxidative Stress in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Antioxidants 13:1363","journal-title":"Antioxidants"},{"key":"1579_CR7","doi-asserted-by":"crossref","first-page":"e2402241","DOI":"10.1002\/advs.202402241","volume":"11","author":"W Cai","year":"2024","unstructured":"Cai W, Wu S, Ming X, Li Z, Pan D, Yang X, Yang M, Yuan Y, Chen X (2024) IL6 Derived from Macrophages under Intermittent Hypoxia Exacerbates NAFLD by Promoting Ferroptosis via MARCH3-Led Ubiquitylation of GPX4. Adv Sci (Weinh) 11:e2402241","journal-title":"Adv Sci (Weinh)"},{"key":"1579_CR8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.redox.2016.05.003","volume":"9","author":"BA Carlson","year":"2016","unstructured":"Carlson BA, Tobe R, Yefremova E, Tsuji PA, Hoffmann VJ, Schweizer U, Gladyshev VN, Hatfield DL, Conrad M (2016) Glutathione peroxidase 4 and vitamin E cooperatively prevent hepatocellular degeneration. Redox Biol 9:22\u201331","journal-title":"Redox Biol"},{"key":"1579_CR9","doi-asserted-by":"publisher","unstructured":"Cathcart J, Barrett R, Bowness JS, Mukhopadhya A, Lynch R, Dillon JF (2024) 'Accuracy of non\u2010invasive imaging techniques for the diagnosis of MASH in patients with MASLD: a systematic review'.\u00a0Liver Int. https:\/\/doi.org\/10.1111\/liv.16127","DOI":"10.1111\/liv.16127"},{"key":"1579_CR10","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3390\/biology12060864","volume":"12","author":"F Chen","year":"2023","unstructured":"Chen F, Kang R, Liu J, Tang D (2023) The ACSL4 network regulates cell death and autophagy in diseases. Biology 12:864","journal-title":"Biology"},{"key":"1579_CR11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.freeradbiomed.2022.01.012","volume":"180","author":"G-H Chen","year":"2022","unstructured":"Chen G-H, Song C-C, Pantopoulos K, Wei X-L, Zheng H, Luo Z (2022a) Mitochondrial oxidative stress mediated Fe-induced ferroptosis via the NRF2-ARE pathway. Free Radical Biol Med 180:95\u2013107","journal-title":"Free Radical Biol Med"},{"key":"1579_CR12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41418-022-00941-0","volume":"29","author":"J Chen","year":"2022","unstructured":"Chen J, Li X, Ge C, Min J, Wang F (2022b) The multifaceted role of ferroptosis in liver disease. Cell Death Differ 29:467\u2013480","journal-title":"Cell Death Differ"},{"key":"1579_CR13","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","volume":"17","author":"X Chen","year":"2021","unstructured":"Chen X, Li J, Kang R, Klionsky DJ, Tang D (2021) Ferroptosis: machinery and regulation. Autophagy 17:2054\u20132081","journal-title":"Autophagy"},{"key":"1579_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15586\/jkcvhl.v8i2.170","volume":"8","author":"WSW Choi","year":"2021","unstructured":"Choi WSW, Boland J, Lin J (2021) Hypoxia-inducible factor-2\u03b1 as a novel target in renal cell carcinoma. J Kidney Can VHL 8:1","journal-title":"J Kidney Can VHL"},{"key":"1579_CR15","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41591-021-01324-7","volume":"27","author":"TK Choueiri","year":"2021","unstructured":"Choueiri TK, Bauer TM, Papadopoulos KP, Plimack ER, Merchan JR, McDermott DF, Dror Michaelson M, Appleman LJ, Thamake S, Perini RF (2021) Inhibition of hypoxia-inducible factor-2\u03b1 in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis. Nat Med 27:802\u2013805","journal-title":"Nat Med"},{"key":"1579_CR16","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41589-021-00751-4","volume":"17","author":"M Conlon","year":"2021","unstructured":"Conlon M, Poltorack CD, Forcina GC, Armenta DA, Mallais M, Perez MA, Wells A, Kahanu A, Magtanong L, Watts JL, Pratt DA, Dixon SJ (2021) A compendium of kinetic modulatory profiles identifies ferroptosis regulators. Nat Chem Biol 17:665\u2013674","journal-title":"Nat Chem Biol"},{"key":"1579_CR17","doi-asserted-by":"crossref","first-page":"108373","DOI":"10.1016\/j.pharmthera.2023.108373","volume":"244","author":"I Costa","year":"2023","unstructured":"Costa I, Barbosa DJ, Benfeito S, Silva V, Chavarria D, Borges F, Remi\u00e3o F, Silva R (2023) Molecular mechanisms of ferroptosis and their involvement in brain diseases. Pharmacol Ther 244:108373","journal-title":"Pharmacol Ther"},{"key":"1579_CR18","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1016\/j.molcel.2023.09.025","volume":"83","author":"S Cui","year":"2023","unstructured":"Cui S, Ghai A, Deng Y, Li S, Zhang R, Egbulefu C, Liang G, Achilefu S, Ye J (2023) Identification of hyperoxidized PRDX3 as a ferroptosis marker reveals ferroptotic damage in chronic liver diseases. Mol Cell 83:3931\u201339.e5","journal-title":"Mol Cell"},{"key":"1579_CR19","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/apt.15173","volume":"49","author":"AJ Czaja","year":"2019","unstructured":"Czaja AJ (2019) Review article: iron disturbances in chronic liver diseases other than haemochromatosis - pathogenic, prognostic, and therapeutic implications. Aliment Pharmacol Ther 49:681\u2013701","journal-title":"Aliment Pharmacol Ther"},{"key":"1579_CR20","doi-asserted-by":"publisher","unstructured":"DiStefano JK (2020) 'NAFLD and NASH in postmenopausal women: implications for diagnosis and treatment'. Endocrinology\u00a0161.\u00a0https:\/\/doi.org\/10.1210\/endocr\/bqaa134","DOI":"10.1210\/endocr\/bqaa134"},{"key":"1579_CR21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2001.25540","volume":"121","author":"JB Dixon","year":"2001","unstructured":"Dixon JB, Bhathal PS, O\u2019Brien PE (2001) Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121:91\u2013100","journal-title":"Gastroenterology"},{"key":"1579_CR22","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B 3rd, Stockwell BR (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149:1060\u20131072","journal-title":"Cell"},{"key":"1579_CR23","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, Goya Grocin A, Xavier da Silva TN, Panzilius E, Scheel CH, Mour\u00e3o A, Buday K, Sato M, Wanninger J, Vignane T, Mohana V, Rehberg M, Flatley A, Schepers A, Kurz A, White D, Sauer M, Sattler M, Tate EW, Schmitz W, Schulze A, O\u2019Donnell V, Proneth B, Popowicz GM, Pratt DA, Angeli JPF, Conrad M (2019) FSP1 is a glutathione-independent ferroptosis suppressor. Nature 575:693\u2013698","journal-title":"Nature"},{"key":"1579_CR24","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.3390\/cancers15143723","volume":"15","author":"J Fang","year":"2023","unstructured":"Fang J, Celton-Morizur S, Desdouets C (2023) NAFLD-related HCC: focus on the latest relevant preclinical models. Cancers 15:3723","journal-title":"Cancers"},{"key":"1579_CR25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s13046-024-03222-5","volume":"43","author":"Ji Feng","year":"2024","unstructured":"Feng Ji, Bin J-L, Liao X-W, Yong Wu, Tang Y, Pei-Zhi Lu, Zhu G-Z, Cui Q-R, Dan YY, Yang G-H (2024) The prognostic role of ACSL4 in postoperative adjuvant TACE-treated HCC: implications for therapeutic response and mechanistic insights. J Exp Clin Cancer Res 43:306","journal-title":"J Exp Clin Cancer Res"},{"key":"1579_CR26","doi-asserted-by":"crossref","first-page":"708959","DOI":"10.3389\/fimmu.2021.708959","volume":"12","author":"TCM Fontes-Cal","year":"2021","unstructured":"Fontes-Cal TCM, Mattos RT, Medeiros NI, Pinto BF, Belchior-Bezerra M, Roque-Souza B, Dutra WO, Ferrari TCA, Vidigal PVT, Faria LC (2021) Crosstalk between plasma cytokines, inflammation, and liver damage as a new strategy to monitoring NAFLD progression. Front Immunol 12:708959","journal-title":"Front Immunol"},{"key":"1579_CR27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1572-0241.2006.01041.x","volume":"102","author":"PM Gholam","year":"2007","unstructured":"Gholam PM, Flancbaum L, Machan JT, Charney DA, Kotler DP (2007) Nonalcoholic fatty liver disease in severely obese subjects. Am J Gastroenterol 102:399\u2013408","journal-title":"Am J Gastroenterol"},{"key":"1579_CR28","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.7150\/ijbs.85883","volume":"19","author":"Q Guan","year":"2023","unstructured":"Guan Q, Wang Z, Keyu Hu, Cao J, Dong Y, Chen Y (2023) Melatonin ameliorates hepatic ferroptosis in NAFLD by inhibiting ER stress via the MT2\/cAMP\/PKA\/IRE1 signaling pathway. Int J Biol Sci 19:3937","journal-title":"Int J Biol Sci"},{"key":"1579_CR29","doi-asserted-by":"crossref","first-page":"e220181","DOI":"10.1148\/rg.220181","volume":"43","author":"FF Guglielmo","year":"2023","unstructured":"Guglielmo FF, Barr RG, Yokoo T, Ferraioli G, Lee JT, Dillman JR, Horowitz JM, Jhaveri KS, Miller FH, Modi RY, Mojtahed A, Ohliger MA, Pirasteh A, Reeder SB, Shanbhogue K, Silva AC, Smith EN, Surabhi VR, Taouli B, Welle CL, Yeh BM, Venkatesh SK (2023) Liver Fibrosis, Fat, and Iron Evaluation with MRI and Fibrosis and Fat Evaluation with US: A Practical Guide for Radiologists. Radiographics 43:e220181","journal-title":"Radiographics"},{"key":"1579_CR30","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s10020-023-00721-7","volume":"29","author":"T Guo","year":"2023","unstructured":"Guo T, Yan W, Cui X, Liu N, Wei X, Sun Y, Fan K, Liu J, Zhu Y, Wang Z, Zhang Y, Chen L (2023) Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK\/ACC signaling and inhibiting ferroptosis. Mol Med 29:132","journal-title":"Mol Med"},{"key":"1579_CR31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12944-020-01393-6","volume":"19","author":"W Guo","year":"2020","unstructured":"Guo W, Lu J, Qin P, Li X, Zhu W, Wu J, Xu N, Zhang Q (2020) The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults. Lipids Health Dis 19:218","journal-title":"Lipids Health Dis"},{"key":"1579_CR32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.redox.2017.01.021","volume":"12","author":"WS Hambright","year":"2017","unstructured":"Hambright WS, Fonseca RS, Chen L, Na R, Qitao R (2017) Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration. J Redox biology 12:8\u201317","journal-title":"J Redox biology"},{"key":"1579_CR33","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer MJ, Viswanathan VS, Ryan MJ, Bole D, Eaton JK, Matov A, Galeas J, Dhruv HD, Berens ME, Schreiber SL (2017) Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. J Nature 551:247\u201350","journal-title":"J Nature"},{"key":"1579_CR34","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jhep.2023.03.016","volume":"79","author":"F He","year":"2023","unstructured":"He F, Zhang P, Liu J, Wang R, Kaufman RJ, Yaden BC, Karin M (2023) ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis. J Hepatol 79:362\u2013377","journal-title":"J Hepatol"},{"key":"1579_CR35","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1111\/liv.15455","volume":"42","author":"H He","year":"2022","unstructured":"He H, Liao S, Zeng Y, Liang L, Chen J, Tao C (2022) Causal relationships between metabolic-associated fatty liver disease and iron status: Two-sample Mendelian randomization. Liver Int 42:2759\u20132768","journal-title":"Liver Int"},{"key":"1579_CR36","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/hep4.2012","volume":"6","author":"CC Hsu","year":"2022","unstructured":"Hsu CC, Senussi NH, Fertrin KY, Kowdley KV (2022) Iron overload disorders. Hepatol Commun 6:1842\u20131854","journal-title":"Hepatol Commun"},{"key":"1579_CR37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.31083\/j.fbl2906221","volume":"29","author":"M Huang","year":"2024","unstructured":"Huang M, Wang Y, Wu X, Li W (2024) Crosstalk between Endoplasmic Reticulum Stress and Ferroptosis in Liver Diseases. Front Biosci (Landmark Ed) 29:221","journal-title":"Front Biosci (Landmark Ed)"},{"key":"1579_CR38","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ijc.34048","volume":"151","author":"Y Huang","year":"2022","unstructured":"Huang Y, Jia M, Yang X, Han H, Hou G, Bi L, Yang Y, Zhang R, Zhao X, Peng C (2022) Annexin A2: The diversity of pathological effects in tumorigenesis and immune response. Int J Cancer 151:497\u2013509","journal-title":"Int J Cancer"},{"key":"1579_CR39","doi-asserted-by":"crossref","first-page":"188848","DOI":"10.1016\/j.bbcan.2022.188848","volume":"1878","author":"Y Huang","year":"2023","unstructured":"Huang Y, Wang S, Ke A, Guo K (2023) Ferroptosis and its interaction with tumor immune microenvironment in liver cancer. Biochim Biophys Acta Rev Cancer 1878:188848","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1579_CR40","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jhep.2023.08.030","volume":"79","author":"AL Hutchison","year":"2023","unstructured":"Hutchison AL, Tavaglione F, Romeo S, Charlton M (2023) Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance. J Hepatol 79:1524\u20131541","journal-title":"J Hepatol"},{"key":"1579_CR41","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jhep.2013.12.009","volume":"60","author":"J Hyysalo","year":"2014","unstructured":"Hyysalo J, M\u00e4nnist\u00f6 VT, Zhou Y, Arola J, K\u00e4rj\u00e4 V, Leivonen M, Juuti A, Jaser N, Lallukka S, K\u00e4kel\u00e4 P, Venesmaa S, Simonen M, Saltevo J, Moilanen L, Korpi-Hy\u00f6valti E, Kein\u00e4nen-Kiukaanniemi S, Oksa H, Orho-Melander M, Valenti L, Fargion S, Pihlajam\u00e4ki J, Peltonen M, Yki-J\u00e4rvinen H (2014) A population-based study on the prevalence of NASH using scores validated against liver histology. J Hepatol 60:839\u2013846","journal-title":"J Hepatol"},{"key":"1579_CR42","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cmet.2015.05.002","volume":"22","author":"S Jenkitkasemwong","year":"2015","unstructured":"Jenkitkasemwong S, Wang CY, Coffey R, Zhang W, Chan A, Biel T, Kim JS, Hojyo S, Fukada T, Knutson MD (2015) SLC39A14 Is Required for the Development of Hepatocellular Iron Overload in Murine Models of Hereditary Hemochromatosis. Cell Metab 22:138\u2013150","journal-title":"Cell Metab"},{"key":"1579_CR43","first-page":"174","volume":"11","author":"J Ji","year":"2022","unstructured":"Ji J, Wu L, Wei J, Wu J, Guo C (2022) The gut microbiome and ferroptosis in MAFLD. J Clin Transl Hepatol 11:174","journal-title":"J Clin Transl Hepatol"},{"key":"1579_CR44","first-page":"174","volume":"11","author":"J Ji","year":"2023","unstructured":"Ji J, Wu L, Wei J, Wu J, Guo C (2023) The Gut Microbiome and Ferroptosis in MAFLD. J Clin Transl Hepatol 11:174\u2013187","journal-title":"J Clin Transl Hepatol"},{"key":"1579_CR45","doi-asserted-by":"crossref","first-page":"102963","DOI":"10.1016\/j.redox.2023.102963","volume":"68","author":"T Jiang","year":"2023","unstructured":"Jiang T, Xiao Y, Zhou J, Luo Z, Yu L, Liao Q, Liu S, Qi X, Zhang H, Hou M, Miao W, Batsaikhan B, Damba T, Liang Y, Li Y, Zhou L (2023) Arbutin alleviates fatty liver by inhibiting ferroptosis via FTO\/SLC7A11 pathway. Redox Biol 68:102963","journal-title":"Redox Biol"},{"key":"1579_CR46","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3389\/fonc.2020.00727","volume":"10","author":"Li Jin","year":"2020","unstructured":"Jin Li, Shen F, Weinfeld M, Sergi C (2020) Insulin growth factor binding protein 7 (IGFBP7)-related cancer and IGFBP3 and IGFBP7 crosstalk. Front Oncol 10:727","journal-title":"Front Oncol"},{"key":"1579_CR47","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jhep.2023.04.002","volume":"79","author":"M Kjaergaard","year":"2023","unstructured":"Kjaergaard M, Lindvig KP, Thorhauge KH, Andersen P, Hansen JK, Kastrup N, Jensen JM, Hansen CD, Johansen S, Israelsen M, Torp N, Trelle MB, Shan S, Detlefsen S, Antonsen S, Andersen JE, Graupera I, Gin\u00e9s P, Thiele M, Krag A (2023) Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease. J Hepatol 79:277\u2013286","journal-title":"J Hepatol"},{"key":"1579_CR48","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1038\/s41467-022-29905-1","volume":"13","author":"P Koppula","year":"2022","unstructured":"Koppula P, Lei G, Zhang Y, Yan Y, Mao C, Kondiparthi L, Shi J, Liu X, Horbath A, Das M, Li W, Poyurovsky MV, Olszewski K, Gan B (2022) A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers. Nat Commun 13:2206","journal-title":"Nat Commun"},{"key":"1579_CR49","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1053\/j.gastro.2009.06.005","volume":"137","author":"A Kotronen","year":"2009","unstructured":"Kotronen A, Peltonen M, Hakkarainen A, Sevastianova K, Bergholm R, Johansson LM, Lundbom N, Rissanen A, Ridderstr\u00e5le M, Groop L, Orho-Melander M, Yki-J\u00e4rvinen H (2009) Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology 137:865\u2013872","journal-title":"Gastroenterology"},{"key":"1579_CR50","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.gtc.2019.02.002","volume":"48","author":"M Lai","year":"2019","unstructured":"Lai M, Afdhal NH (2019) Liver Fibrosis Determination. Gastroenterol Clin North Am 48:281\u2013289","journal-title":"Gastroenterol Clin North Am"},{"key":"1579_CR51","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.3748\/wjg.v30.i32.3730","volume":"30","author":"MS Lai","year":"2024","unstructured":"Lai MS, Yan XP, Branch DR, Loriamini M, Chen LM (2024) Ferroptosis in liver diseases: Fundamental mechanism and clinical implications. World J Gastroenterol 30:3730\u20133738","journal-title":"World J Gastroenterol"},{"key":"1579_CR52","doi-asserted-by":"crossref","first-page":"102276","DOI":"10.1016\/j.redox.2022.102276","volume":"51","author":"J Lee","year":"2022","unstructured":"Lee J, You JH, Roh JL (2022) Poly(rC)-binding protein 1 represses ferritinophagy-mediated ferroptosis in head and neck cancer. Redox Biol 51:102276","journal-title":"Redox Biol"},{"key":"1579_CR53","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, Kim W, Kim YJ, Yoon JH, Cho SH, Sung MW (2010) Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. J Digestive Liver Dis 42:503\u201308","journal-title":"J Dig Liver Dis"},{"key":"1579_CR54","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N, Sun B, Wang G (2020a) Ferroptosis: past, present and future. Cell Death Dis 11:88","journal-title":"Cell Death Dis"},{"key":"1579_CR55","doi-asserted-by":"crossref","unstructured":"Li J, Liu J, Zhou Z, Wu R, Chen X, Yu C, Stockwell B, Kroemer G, Kang R, Tang D (2023) 'Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer'. Sci Transl Med\u00a015:eadg3049","DOI":"10.1126\/scitranslmed.adg3049"},{"key":"1579_CR56","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1111\/liv.14428","volume":"40","author":"X Li","year":"2020","unstructured":"Li X, Wang TX, Huang X, Li Y, Sun T, Zang S, Guan KL, Xiong Y, Liu J, Yuan HX (2020b) Targeting ferroptosis alleviates methionine-choline deficient (MCD)-diet induced NASH by suppressing liver lipotoxicity. Liver Int 40:1378\u20131394","journal-title":"Liver Int"},{"key":"1579_CR57","doi-asserted-by":"crossref","first-page":"115113","DOI":"10.1016\/j.biopha.2023.115113","volume":"165","author":"Na Li","year":"2023","unstructured":"Li Na, Yin L, Shang J, Liang M, Liu Z, Yang H, Qiang G, Guanhua Du, Yang X (2023b) Kaempferol attenuates nonalcoholic fatty liver disease in type 2 diabetic mice via the Sirt1\/AMPK signaling pathway. Biomed Pharmacother 165:115113","journal-title":"Biomed Pharmacother"},{"key":"1579_CR58","doi-asserted-by":"crossref","first-page":"e2315541121","DOI":"10.1073\/pnas.2315541121","volume":"121","author":"H Li","year":"2024","unstructured":"Li H, Sun Y, Yao Y, Ke S, Zhang N, Xiong W, Shi J, He C, Xiao X, Yu H, Dai P, Xiang B, Xing X, Xu G, Song W, Song J, Zhang J (2024) USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy. Proc Natl Acad Sci U S A 121:e2315541121","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1579_CR59","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.molmed.2023.05.013","volume":"29","author":"W Li","year":"2023","unstructured":"Li W, Liang L, Liu S, Yi H, Zhou Y (2023c) FSP1: a key regulator of ferroptosis. Trends Mol Med 29:753\u2013764","journal-title":"Trends Mol Med"},{"key":"1579_CR60","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1016\/j.cell.2023.05.003","volume":"186","author":"D Liang","year":"2023","unstructured":"Liang D, Feng Y, Zandkarimi F, Wang H, Zhang Z, Kim J, Cai Y, Gu W, Stockwell BR, Jiang X (2023) Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell 186:2748\u201364.e22","journal-title":"Cell"},{"key":"1579_CR61","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","volume":"82","author":"D Liang","year":"2022","unstructured":"Liang D, Minikes AM, Jiang X (2022) Ferroptosis at the intersection of lipid metabolism and cellular signaling. Mol Cell 82:2215\u20132227","journal-title":"Mol Cell"},{"key":"1579_CR62","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1016\/j.cmet.2024.09.007","volume":"36","author":"H Lin","year":"2024","unstructured":"Lin H, Ma C, Zhuang X, Liu S, Liu D, Zhang M, Lu Y, Zhou G, Zhang C, Wang T, Zhang Z, Lv L, Zhang D, Ruan XZ, Xu Y, Chai R, Yu X, Sun JP, Chu B (2024) Sensing steroid hormone 17\u03b1-hydroxypregnenolone by GPR56 enables protection from ferroptosis-induced liver injury. Cell Metab 36:2402\u201318.e10","journal-title":"Cell Metab"},{"key":"1579_CR63","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41419-023-06045-y","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, Lu S, Wu LL, Yang L, Yang L, Wang J (2023a) The diversified role of mitochondria in ferroptosis in cancer. Cell Death Dis 14:519","journal-title":"Cell Death Dis"},{"key":"1579_CR64","doi-asserted-by":"crossref","first-page":"188890","DOI":"10.1016\/j.bbcan.2023.188890","volume":"1878","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wan Y, Jiang Y, Zhang L, Cheng W (2023b) GPX4: The hub of lipid oxidation, ferroptosis, disease and treatment. Biochim Biophys Acta Rev Cancer 1878:188890","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1579_CR65","doi-asserted-by":"crossref","unstructured":"Liu Z, Wang H, Larsen M, Gunewardana S, Cendali FI, Reisz JA, Akiyama H, Behringer RR, Ma Q, Sue S, Hammoud. (2022) The solute carrier family 7 member 11 (SLC7A11) is regulated by LH\/androgen and required for cystine\/glutathione homeostasis in mouse Sertoli cells. Mol Cell Endocrinol 549:111641","DOI":"10.1016\/j.mce.2022.111641"},{"key":"1579_CR66","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00109-023-02308-5","volume":"101","author":"M Luo","year":"2023","unstructured":"Luo M, Li T, Sang H (2023) The role of hypoxia-inducible factor 1\u03b1 in hepatic lipid metabolism. J Mol Med 101:487\u2013500","journal-title":"J Mol Med"},{"key":"1579_CR67","doi-asserted-by":"crossref","first-page":"5933","DOI":"10.1038\/s41467-023-41626-7","volume":"14","author":"Y Lv","year":"2023","unstructured":"Lv Y, Liang C, Sun Q, Zhu J, Xu H, Li X, Li YY, Wang Q, Yuan H, Chu B, Zhu D (2023) Structural insights into FSP1 catalysis and ferroptosis inhibition. Nat Commun 14:5933","journal-title":"Nat Commun"},{"key":"1579_CR68","doi-asserted-by":"crossref","first-page":"115242","DOI":"10.1016\/j.bcp.2022.115242","volume":"205","author":"C Ma","year":"2022","unstructured":"Ma C, Han L, Zhu Z, Heng Pang C, Pan G (2022) Mineral metabolism and ferroptosis in non-alcoholic fatty liver diseases. Biochem Pharmacol 205:115242","journal-title":"Biochem Pharmacol"},{"key":"1579_CR69","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature13148","volume":"509","author":"JD Mancias","year":"2014","unstructured":"Mancias JD, Wang X, Gygi SP, Harper JW, Kimmelman AC (2014) Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature 509:105\u2013109","journal-title":"Nature"},{"key":"1579_CR70","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee H, Koppula P, Wu S, Zhuang L, Fang B, Poyurovsky MV, Olszewski K, Gan B (2021) DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature 593:586\u2013590","journal-title":"Nature"},{"key":"1579_CR71","doi-asserted-by":"crossref","first-page":"453","DOI":"10.11152\/mu-2850","volume":"23","author":"RC Mares","year":"2021","unstructured":"Mares RC, Marginean CO (2021) Noninvasive diagnosis of liver fibrosis in the complex cardiac malformation survivors - a review of the literature. Med Ultrason 23:453\u2013462","journal-title":"Med Ultrason"},{"key":"1579_CR72","doi-asserted-by":"crossref","first-page":"6613827","DOI":"10.1155\/2021\/6613827","volume":"2021","author":"M Maru\u0161i\u0107","year":"2021","unstructured":"Maru\u0161i\u0107 M, Pai\u0107 M, Knobloch M, Liberati Pr\u0161o AM (2021) NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2. Can J Gastroenterol Hepatol 2021:6613827","journal-title":"Can J Gastroenterol Hepatol"},{"key":"1579_CR73","doi-asserted-by":"crossref","first-page":"103847","DOI":"10.1016\/j.ebiom.2022.103847","volume":"76","author":"Y Miao","year":"2022","unstructured":"Miao Y, Chen Y, Xue F, Liu K, Zhu B, Gao J, Yin J, Zhang C, Li G (2022) Contribution of ferroptosis and GPX4\u2019s dual functions to osteoarthritis progression. EBioMedicine 76:103847","journal-title":"EBioMedicine"},{"key":"1579_CR74","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3390\/ijms25010342","volume":"25","author":"DO Moon","year":"2023","unstructured":"Moon DO (2023) NADPH Dynamics: Linking Insulin Resistance and \u03b2-Cells Ferroptosis in Diabetes Mellitus. Int J Mol Sci 25:342","journal-title":"Int J Mol Sci"},{"key":"1579_CR75","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou Y, Wang J, Wu J, He D, Zhang C, Duan C, Li B (2019) Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol 12:34","journal-title":"J Hematol Oncol"},{"key":"1579_CR76","doi-asserted-by":"crossref","unstructured":"Mullen NJ, Shukla SK, Thakur R, Kollala SS, Wang D, Chaika N, Santana JF, Miklavcic WR, LaBreck DA, Mallareddy JR, Price DH, Natarajan A, Mehla K, Sykes DB, Hollingsworth MA, Singh PK (2024) 'DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation'.\u00a0Elife\u00a012:2023.04.03.535399","DOI":"10.7554\/eLife.87292.3"},{"key":"1579_CR77","doi-asserted-by":"crossref","unstructured":"Nakamura T, Hipp C, Santos Dias Mour\u00e3o A, Borggr\u00e4fe J, Aldrovandi M, Henkelmann B, Wanninger J, Mishima E, Lytton E, Emler D, Proneth B, Sattler M, Conrad M (2023) Phase separation of FSP1 promotes ferroptosis. Nature 619:371\u2013377","DOI":"10.1038\/s41586-023-06255-6"},{"key":"1579_CR78","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3390\/biom12060824","volume":"12","author":"F Nassir","year":"2022","unstructured":"Nassir F (2022) NAFLD: mechanisms, treatments, and biomarkers. Biomolecules 12:824","journal-title":"Biomolecules"},{"key":"1579_CR79","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","volume":"306","author":"E Nemeth","year":"2004","unstructured":"Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090\u20132093","journal-title":"Science"},{"key":"1579_CR80","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s41556-022-00973-1","volume":"24","author":"KT Nguyen","year":"2022","unstructured":"Nguyen KT, Mun SH, Yang J, Lee J, Seok OH, Kim E, Kim D, An SY, Seo DY, Suh JY, Lee Y, Hwang CS (2022) The MARCHF6 E3 ubiquitin ligase acts as an NADPH sensor for the regulation of ferroptosis. Nat Cell Biol 24:1239\u20131251","journal-title":"Nat Cell Biol"},{"key":"1579_CR81","doi-asserted-by":"crossref","unstructured":"Ohshima T, Yamamoto H, Sakamaki Y, Saito C, Mizushima N (2022) 'NCOA4 drives ferritin phase separation to facilitate macroferritinophagy and microferritinophagy'.\u00a0J Cell Biol\u00a0221:e202203102","DOI":"10.1083\/jcb.202203102"},{"key":"1579_CR82","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1007\/s10571-023-01337-5","volume":"43","author":"M Pan","year":"2023","unstructured":"Pan M, Li X, Guangchen Xu, Tian X, Li Y, Fang W (2023) Tripartite motif protein family in central nervous system diseases. Cell Mol Neurobiol 43:2567\u20132589","journal-title":"Cell Mol Neurobiol"},{"key":"1579_CR83","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.7150\/ijms.62903","volume":"18","author":"Q Pan","year":"2021","unstructured":"Pan Q, Luo Y, Xia Q, He K (2021) Ferroptosis and Liver Fibrosis. Int J Med Sci 18:3361\u20133366","journal-title":"Int J Med Sci"},{"key":"1579_CR84","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.2174\/1381612825666190117102111","volume":"24","author":"M Papatheodoridi","year":"2018","unstructured":"Papatheodoridi M, Cholongitas E (2018) Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Concepts. Curr Pharm des 24:4574\u20134586","journal-title":"Curr Pharm des"},{"key":"1579_CR85","doi-asserted-by":"crossref","unstructured":"Piazzolla VA, Mangia A (2020) 'Noninvasive diagnosis of NAFLD and NASH'.\u00a0Cells\u00a09:1005","DOI":"10.3390\/cells9041005"},{"key":"1579_CR86","doi-asserted-by":"crossref","unstructured":"Popa SL, Ismaiel A, Abenavoli L, Padureanu AM, Dita MO, Bolchis R, Munteanu MA, Brata VD, Pop C, Bosneag A, Dumitrascu DI, Barsan M, David L (2023) 'Diagnosis of Liver Fibrosis Using Artificial Intelligence: A Systematic Review'. Medicina (Kaunas)\u00a059:992","DOI":"10.3390\/medicina59050992"},{"key":"1579_CR87","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","volume":"22","author":"S Pouwels","year":"2022","unstructured":"Pouwels S, Sakran N, Graham Y, Leal A, Pintar T, Yang W, Kassir R, Singhal R, Mahawar K, Ramnarain D (2022) Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disord 22:63","journal-title":"BMC Endocr Disord"},{"key":"1579_CR88","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-230X-6-34","volume":"6","author":"T Poynard","year":"2006","unstructured":"Poynard T, Ratziu V, Charlotte F, Messous D, Munteanu M, Imbert-Bismut F, Massard J, Bonyhay L, Tahiri M, Thabut D, Cadranel JF, Le Bail B, de Ledinghen V (2006) Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol 6:34","journal-title":"BMC Gastroenterol"},{"key":"1579_CR89","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.hbpd.2023.10.005","volume":"23","author":"ZB Qian","year":"2024","unstructured":"Qian ZB, Li JF, Xiong WY, Mao XR (2024) Ferritinophagy: A new idea for liver diseases regulated by ferroptosis. Hepatobiliary Pancreat Dis Int 23:160\u2013170","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"1579_CR90","doi-asserted-by":"crossref","first-page":"1303426","DOI":"10.3389\/fendo.2023.1303426","volume":"14","author":"J Qin","year":"2023","unstructured":"Qin J, Cao P, Ding X, Zeng Z, Deng L, Luo L (2023a) Machine learning identifies ferroptosis-related gene ANXA2 as potential diagnostic biomarkers for NAFLD. Front Endocrinol (Lausanne) 14:1303426","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1579_CR91","doi-asserted-by":"crossref","first-page":"1303426","DOI":"10.3389\/fendo.2023.1303426","volume":"14","author":"J Qin","year":"2023","unstructured":"Qin J, Cao P, Ding X, Zeng Z, Deng L, Luo L (2023b) Machine learning identifies ferroptosis-related gene ANXA2 as potential diagnostic biomarkers for NAFLD. Front Endocrinol 14:1303426","journal-title":"Front Endocrinol"},{"key":"1579_CR92","doi-asserted-by":"crossref","first-page":"24417","DOI":"10.1021\/acs.jafc.4c04929","volume":"72","author":"J Qiu","year":"2024","unstructured":"Qiu J, Le Y, Liu N, Chen L, Jiang Y, Wang Y, Fan X, Rong X, Zhiling Yu, Li S (2024) Nuciferine Alleviates High-Fat Diet-and ApoE\u2013\/\u2013-Induced Hepatic Steatosis and Ferroptosis in NAFLD Mice via the PPAR\u03b1 Signaling Pathway. J Agric Food Chem 72:24417\u201324431","journal-title":"J Agric Food Chem"},{"key":"1579_CR93","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/cns.13548","volume":"27","author":"X-F Qu","year":"2021","unstructured":"Qu X-F, Liang T-y, De-gang Wu, Lai N-S, Deng R-M, Ma C, Li X, Li H-Y, Liu Y-Z, Shen H-T (2021) Acyl-CoA synthetase long chain family member 4 plays detrimental role in early brain injury after subarachnoid hemorrhage in rats by inducing ferroptosis. CNS Neurosci Ther 27:449\u2013463","journal-title":"CNS Neurosci Ther"},{"key":"1579_CR94","first-page":"137","volume":"23","author":"A Radosz","year":"2019","unstructured":"Radosz A, Obuchowicz A (2019) The role of hepcidin in regulating iron homeostasis in selected diseases. Dev Period Med 23:137\u2013141","journal-title":"Dev Period Med"},{"key":"1579_CR95","doi-asserted-by":"publisher","unstructured":"Ren X, Chen H, Wang H, Wang Y, Huang C, Pan H (2024) Advances in the pharmacological effects and mechanisms of Nelumbo nucifera Gaertn. extract Nuciferine. J Ethnopharmacol 118262.\u00a0https:\/\/doi.org\/10.1016\/j.jep.2024.118262","DOI":"10.1016\/j.jep.2024.118262"},{"key":"1579_CR96","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/17474124.2025.2450717","volume":"19","author":"R Righetti","year":"2025","unstructured":"Righetti R, Cinque F, Patel K, Sebastiani G (2025) The role of noninvasive biomarkers for monitoring cell injury in advanced liver fibrosis. Expert Rev Gastroenterol Hepatol 19:65\u201380","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"1579_CR97","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bcmd.2017.09.009","volume":"69","author":"MS Ryu","year":"2018","unstructured":"Ryu MS, Duck KA, Philpott CC (2018) Ferritin iron regulators, PCBP1 and NCOA4, respond to cellular iron status in developing red cells. Blood Cells Mol Dis 69:75\u201381","journal-title":"Blood Cells Mol Dis"},{"key":"1579_CR98","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev-med-042220-020407","volume":"73","author":"Y Saiman","year":"2022","unstructured":"Saiman Y, Duarte-Rojo A, Rinella ME (2022) Fatty Liver Disease: Diagnosis and Stratification. Annu Rev Med 73:529\u2013544","journal-title":"Annu Rev Med"},{"key":"1579_CR99","doi-asserted-by":"crossref","unstructured":"Sakurai Y, Kubota N, Yamauchi T, Kadowaki T (2021) 'Role of insulin resistance in MAFLD'.\u00a0Int J Mol Sci\u00a022:4156","DOI":"10.3390\/ijms22084156"},{"key":"1579_CR100","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1074\/jbc.TM118.004166","volume":"294","author":"CE Samuel","year":"2019","unstructured":"Samuel CE (2019) Adenosine deaminase acting on RNA (ADAR1), a suppressor of double-stranded RNA\u2013triggered innate immune responses. J Biol Chem 294:1710\u20131720","journal-title":"J Biol Chem"},{"key":"1579_CR101","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3945\/an.116.013961","volume":"8","author":"V Sangkhae","year":"2017","unstructured":"Sangkhae V, Nemeth E (2017) Regulation of the Iron Homeostatic Hormone Hepcidin. Adv Nutr 8:126\u2013136","journal-title":"Adv Nutr"},{"key":"1579_CR102","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-3-030-62026-4_4","volume":"1301","author":"N Santana-Codina","year":"2021","unstructured":"Santana-Codina N, Gikandi A, Mancias JD (2021) The Role of NCOA4-Mediated Ferritinophagy in Ferroptosis. Adv Exp Med Biol 1301:41\u201357","journal-title":"Adv Exp Med Biol"},{"key":"1579_CR103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1744-859X-4-13","volume":"4","author":"CM Schr\u00f6der","year":"2005","unstructured":"Schr\u00f6der CM, O\u2019Hara R (2005) Depression and obstructive sleep apnea (OSA). Ann Gen Psychiatry 4:1\u20138","journal-title":"Ann Gen Psychiatry"},{"key":"1579_CR104","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1172\/JCI122359","volume":"129","author":"AJ Schwartz","year":"2019","unstructured":"Schwartz AJ, Das NK, Ramakrishnan SK, Jain C, Jurkovic MT, Wu J, Nemeth E, Lakhal-Littleton S, Colacino JA, Shah YM (2019) Hepatic hepcidin\/intestinal HIF-2\u03b1 axis maintains iron absorption during iron deficiency and overload. J Clin Invest 129:336\u2013348","journal-title":"J Clin Invest"},{"key":"1579_CR105","doi-asserted-by":"crossref","first-page":"127048","DOI":"10.1016\/j.jtemb.2022.127048","volume":"74","author":"Y Shen","year":"2022","unstructured":"Shen Y, Huang H, Wang Y, Yang R, Ke X (2022) Antioxidant effects of Se-glutathione peroxidase in alcoholic liver disease. J Trace Elem Med Biol 74:127048","journal-title":"J Trace Elem Med Biol"},{"key":"1579_CR106","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/0270-9139(95)90052-7","volume":"21","author":"P Stal","year":"1995","unstructured":"Stal P, Broom\u00e9 U, Scheynius A, Befrits R, Hultcrantz R (1995) Kupffer cell iron overload induces intercellular adhesion molecule-1 expression on hepatocytes in genetic hemochromatosis. J Hepatol 21:1308\u201316","journal-title":"J Hepatol"},{"key":"1579_CR107","doi-asserted-by":"crossref","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, Sulkowski MS, Torriani FJ, Dieterich DT, Thomas DL, Messinger D, Nelson M (2006) Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology 43:1317\u20131325","DOI":"10.1002\/hep.21178"},{"key":"1579_CR108","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gasc\u00f3n S, Hatzios SK, Kagan VE, Noel K, Jiang X, Linkermann A, Murphy ME, Overholtzer M, Oyagi A, Pagnussat GC, Park J, Ran Q, Rosenfeld CS, Salnikow K, Tang D, Torti FM, Torti SV, Toyokuni S, Woerpel KA, Zhang DD (2017) \u2019Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease\u2019. Cell 171:273\u2013285","journal-title":"Cell"},{"key":"1579_CR109","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1749-6632.1988.tb55510.x","volume":"526","author":"G Strohmeyer","year":"1988","unstructured":"Strohmeyer G, Niederau C, Stremmel W (1988) Survival and causes of death in hemochromatosis. Observations in 163 patients. Ann N Y Acad Sci 526:245\u2013257","journal-title":"Ann N Y Acad Sci"},{"key":"1579_CR110","doi-asserted-by":"crossref","first-page":"110108","DOI":"10.1016\/j.biopha.2020.110108","volume":"127","author":"Y Sun","year":"2020","unstructured":"Sun Y, Chen P, Zhai B, Zhang M, Xiang Y, Fang J, Xu S, Gao Y, Chen X, Sui X, Li G (2020) The emerging role of ferroptosis in inflammation. Biomed Pharmacother 127:110108","journal-title":"Biomed Pharmacother"},{"key":"1579_CR111","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41419-018-0794-4","volume":"9","author":"Y Sun","year":"2018","unstructured":"Sun Y, Zheng Y, Wang C, Liu Y (2018) Glutathione depletion induces ferroptosis, autophagy, and premature cell senescence in retinal pigment epithelial cells. Cell Death Dis 9:753","journal-title":"Cell Death Dis"},{"key":"1579_CR112","doi-asserted-by":"crossref","first-page":"167","DOI":"10.31083\/j.rcm2305167","volume":"23","author":"E Tam","year":"2022","unstructured":"Tam E, Reno C, Nguyen K, Cho S, Sweeney G (2022) Importance of autophagy in mediating cellular responses to iron overload in cardiomyocytes. Rev Cardiovasc Med 23:167","journal-title":"Rev Cardiovasc Med"},{"key":"1579_CR113","doi-asserted-by":"crossref","first-page":"3920196","DOI":"10.1155\/2020\/3920196","volume":"2020","author":"DM Tanase","year":"2020","unstructured":"Tanase DM, Gosav EM, Costea CF, Ciocoiu M, Lacatusu CM, Maranduca MA, Ouatu A, Floria M (2020) The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD). J Diabetes Res 2020:3920196","journal-title":"J Diabetes Res"},{"key":"1579_CR114","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G (2021) Ferroptosis: molecular mechanisms and health implications. Cell Res 31:107\u2013125","journal-title":"Cell Res"},{"key":"1579_CR115","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/antiox14010056","volume":"14","author":"F Termite","year":"2025","unstructured":"Termite F, Archilei S, D\u2019Ambrosio F, Petrucci L, Viceconti N, Iaccarino R, Liguori A, Gasbarrini A, Miele L (2025) Gut Microbiota at the Crossroad of Hepatic Oxidative Stress and MASLD. Antioxidants 14:56","journal-title":"Antioxidants"},{"key":"1579_CR116","doi-asserted-by":"crossref","first-page":"102708","DOI":"10.1016\/j.redox.2023.102708","volume":"62","author":"Y Tian","year":"2023","unstructured":"Tian Y, Xie Y, Guo Z, Feng P, You Y, Yu Q (2023) 17\u03b2-oestradiol inhibits ferroptosis in the hippocampus by upregulating DHODH and further improves memory decline after ovariectomy. Redox Biol 62:102708","journal-title":"Redox Biol"},{"key":"1579_CR117","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S2468-1253(23)00066-3","volume":"8","author":"MA Tincopa","year":"2023","unstructured":"Tincopa MA, Loomba R (2023) Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Lancet Gastroenterol Hepatol 8:660\u2013670","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1579_CR118","unstructured":"Tirani MM, Haghjou MM (2019) Reactive oxygen species (ROS), total antioxidant capacity (AOC) and malondialdehyde (MDA) make a triangle in evaluation of zinc stress extension. J An Plant Sci 29(4)"},{"key":"1579_CR119","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/s41401-022-01010-5","volume":"44","author":"J Tong","year":"2023","unstructured":"Tong J, Lan XT, Zhang Z, Liu Y, Sun DY, Wang XJ, Ou-Yang SX, Zhuang CL, Shen FM, Wang P, Li DJ (2023a) Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: potential involvement of PANoptosis. Acta Pharmacol Sin 44:1014\u20131028","journal-title":"Acta Pharmacol Sin"},{"key":"1579_CR120","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/s41401-022-01010-5","volume":"44","author":"J Tong","year":"2023","unstructured":"Tong J, Lan X-T, Zhang Z, Liu Yi, Sun D-Y, Wang X-J, Ou-Yang S-x, Zhuang C-L, Shen F-M, Wang P (2023b) Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: potential involvement of PANoptosis. Acta Pharmacol Sin 44:1014\u20131028","journal-title":"Acta Pharmacol Sin"},{"key":"1579_CR121","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1016\/j.apsb.2022.02.003","volume":"12","author":"J Tong","year":"2022","unstructured":"Tong J, Li D, Meng H, Sun D, Lan X, Ni M, Ma J, Zeng F, Sun S, Jiangtao Fu (2022) Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease. Acta Pharmaceutica Sinica B 12:3650\u20133666","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"1579_CR122","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cmet.2020.06.019","volume":"32","author":"K Vasan","year":"2020","unstructured":"Vasan K, Werner M, Chandel NS (2020) Mitochondrial Metabolism as a Target for Cancer Therapy. Cell Metab 32:341\u2013352","journal-title":"Cell Metab"},{"key":"1579_CR123","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/biof.1797","volume":"48","author":"LA Videla","year":"2022","unstructured":"Videla LA, Valenzuela R (2022) Perspectives in liver redox imbalance: toxicological and pharmacological aspects underlying iron overloading, nonalcoholic fatty liver disease, and thyroid hormone action. BioFactors 48:400\u2013415","journal-title":"BioFactors"},{"key":"1579_CR124","first-page":"518","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS (2003) A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38:518\u2013526","journal-title":"Hepatology"},{"key":"1579_CR125","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/ng2059","volume":"39","author":"F Wang","year":"2007","unstructured":"Wang F, Paradkar PN, Custodio AO, McVey Ward D, Fleming MD, Campagna D, Roberts KA, Boyartchuk V, Dietrich WF, Kaplan J, Andrews NC (2007) Genetic variation in Mon1a affects protein trafficking and modifies macrophage iron loading in mice. Nat Genet 39:1025\u20131032","journal-title":"Nat Genet"},{"key":"1579_CR126","first-page":"153303382098078","volume":"19","author":"R Wang","year":"2020","unstructured":"Wang R, Zang W, Hu B, Deng D, Ling X, Zhou H, Su M, Jiang J (2020) Serum ESPL1 Can Be Used as a Biomarker for Patients With Hepatitis B Virus-Related Liver Cancer: A Chinese Case-Control Study. Technol Cancer Res Treat 19:1533033820980785","journal-title":"Technol Cancer Res Treat"},{"key":"1579_CR127","doi-asserted-by":"crossref","first-page":"113374","DOI":"10.1016\/j.biopha.2022.113374","volume":"153","author":"S Wang","year":"2022","unstructured":"Wang S, Liu Z, Geng J, Li L, Feng X (2022a) An overview of ferroptosis in non-alcoholic fatty liver disease. Biomed Pharmacother 153:113374","journal-title":"Biomed Pharmacother"},{"key":"1579_CR128","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41420-022-01011-7","volume":"8","author":"X Wang","year":"2022","unstructured":"Wang X, Ma B, Wen X, You H, Sheng C, Le Bu, Shen Qu (2022b) Bone morphogenetic protein 4 alleviates nonalcoholic steatohepatitis by inhibiting hepatic ferroptosis. Cell Death Discovery 8:234","journal-title":"Cell Death Discovery"},{"key":"1579_CR129","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1038\/s41418-022-01008-w","volume":"29","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zheng L, Shang W, Yang Z, Li T, Liu F, Shao W, Lv L, Chai L, Qu L, Xu Q, Du J, Liang X, Zeng J, Jia J (2022c) Wnt\/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer. Cell Death Differ 29:2190\u20132202","journal-title":"Cell Death Differ"},{"key":"1579_CR130","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.7150\/ijbs.85454","volume":"19","author":"X Wang","year":"2023","unstructured":"Wang X, Kong X, Feng X, Jiang DS (2023a) Effects of DNA, RNA, and Protein Methylation on the Regulation of Ferroptosis. Int J Biol Sci 19:3558\u20133575","journal-title":"Int J Biol Sci"},{"key":"1579_CR131","doi-asserted-by":"crossref","first-page":"122086","DOI":"10.1016\/j.lfs.2023.122086","volume":"332","author":"Y Wang","year":"2023","unstructured":"Wang Y, Bo J, Zhao Z, Han Y, Zhang Q, Liu L (2023b) Depletion of Igfbp7 alleviates zebrafish NAFLD progression through inhibiting hepatic ferroptosis. Life Sci 332:122086","journal-title":"Life Sci"},{"key":"1579_CR132","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41392-023-01720-0","volume":"8","author":"Y Wang","year":"2023","unstructured":"Wang Y, Hu J, Wu S, Fleishman JS, Li Y, Xu Y, Zou W, Wang J, Feng Y, Chen J, Wang H (2023c) Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases. Signal Transduct Target Ther 8:449","journal-title":"Signal Transduct Target Ther"},{"key":"1579_CR133","doi-asserted-by":"crossref","first-page":"102131","DOI":"10.1016\/j.redox.2021.102131","volume":"46","author":"A Wu","year":"2021","unstructured":"Wu A, Feng B, Yu J, Yan L, Che L, Zhuo Y, Luo Y, Yu B, Wu D, Chen D (2021a) Fibroblast growth factor 21 attenuates iron overload-induced liver injury and fibrosis by inhibiting ferroptosis. Redox Biol 46:102131","journal-title":"Redox Biol"},{"key":"1579_CR134","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41420-021-00660-4","volume":"7","author":"J Wu","year":"2021","unstructured":"Wu J, Wang Y, Jiang R, Xue R, Yin X, Wu M, Meng Q (2021b) Ferroptosis in liver disease: new insights into disease mechanisms. Cell Death Discov 7:276","journal-title":"Cell Death Discov"},{"key":"1579_CR135","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.7150\/thno.54113","volume":"11","author":"X Wu","year":"2021","unstructured":"Wu X, Li Y, Zhang S, Zhou X (2021c) Ferroptosis as a novel therapeutic target for cardiovascular disease. Theranostics 11:3052\u20133059","journal-title":"Theranostics"},{"key":"1579_CR136","doi-asserted-by":"crossref","first-page":"101145","DOI":"10.1016\/j.eclinm.2021.101145","volume":"41","author":"XX Wu","year":"2021","unstructured":"Wu XX, Zheng KI, Boursier J, Chan WK, Yilmaz Y, Romero-G\u00f3mez M, El Kassas M, Targher G, Byrne CD, Huang ZM, Zheng MH (2021d) acNASH index to diagnose nonalcoholic steatohepatitis: a prospective derivation and global validation study. EClinicalMedicine 41:101145","journal-title":"EClinicalMedicine"},{"key":"1579_CR137","doi-asserted-by":"crossref","first-page":"1033129","DOI":"10.3389\/fnut.2022.1033129","volume":"9","author":"Q Wu","year":"2022","unstructured":"Wu Q, Chen Z, Ding Y, Tang Y, Cheng Y (2022) Protective effect of traditional Chinese medicine on non-alcoholic fatty liver disease and liver cancer by targeting ferroptosis. Front Nutr 9:1033129","journal-title":"Front Nutr"},{"key":"1579_CR138","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s12072-023-10622-w","volume":"18","author":"H Wu","year":"2024","unstructured":"Wu H, Zhou M, Jin Q, Wang X, Yue Xu, Li M, Chen S, Tang Q, Wang Qi, Baoying Hu (2024a) The upregulation of Annexin A2 by TLR4 pathway facilitates lipid accumulation and liver injury via blocking AMPK\/mTOR-mediated autophagy flux during the development of non-alcoholic fatty liver disease. Hep Intl 18:1144\u20131157","journal-title":"Hep Intl"},{"key":"1579_CR139","doi-asserted-by":"crossref","unstructured":"Wu T, Zhou H, Wang L, Tan J, Gao W, Wu Y, Zhao D, Shen C, Zheng B, Huang X (2024b) TRIM59 is required for mouse GC-1 cell maintenance through modulating the ubiquitination of AXIN1.\u00a0Heliyon\u00a010:e36744","DOI":"10.1016\/j.heliyon.2024.e36744"},{"key":"1579_CR140","first-page":"1","volume":"19","author":"Y Wu","year":"2020","unstructured":"Wu Y, Zhang S, Gong X, Tam S, Xiao D, Liu S, Tao Y (2020) The epigenetic regulators and metabolic changes in ferroptosis-associated cancer progression. Mol Cancer 19:1\u201317","journal-title":"Mol Cancer"},{"key":"1579_CR141","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41374-022-00805-8","volume":"102","author":"R Xiang","year":"2022","unstructured":"Xiang R, Liu Y, Fan L, Jiang B, Wang F (2022) RNA adenosine deaminase (ADAR1) alleviates high-fat diet-induced nonalcoholic fatty liver disease by inhibiting NLRP3 inflammasome. Lab Invest 102:1088\u20131100","journal-title":"Lab Invest"},{"key":"1579_CR142","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/cdd.2015.158","volume":"23","author":"Y Xie","year":"2016","unstructured":"Xie Y, Hou W, Song X, Yu Y, Huang J, Sun X, Kang R, Tang D (2016) Ferroptosis: process and function. Cell Death Differ 23:369\u2013379","journal-title":"Cell Death Differ"},{"key":"1579_CR143","doi-asserted-by":"crossref","first-page":"e52280","DOI":"10.15252\/embr.202052280","volume":"23","author":"G Xing","year":"2022","unstructured":"Xing G, Meng L, Cao S, Liu S, Wu J, Li Q, Huang W, Zhang L (2022) PPAR\u03b1 alleviates iron overload-induced ferroptosis in mouse liver. EMBO Rep 23:e52280","journal-title":"EMBO Rep"},{"key":"1579_CR144","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1007\/s00210-023-02492-8","volume":"396","author":"J Xu","year":"2023","unstructured":"Xu J, Tian H, Ji Y, Dong L, Liu Y, Wang Y, Gao X, Shi H, Li H, Yang L (2023) Urolithin C reveals anti-NAFLD potential via AMPK-ferroptosis axis and modulating gut microbiota. Naunyn Schmiedebergs Arch Pharmacol 396:2687\u20132699","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1579_CR145","doi-asserted-by":"crossref","first-page":"25795","DOI":"10.1021\/acsnano.4c08574","volume":"18","author":"P Xue","year":"2024","unstructured":"Xue P, Zhuang H, Shao S, Bai T, Zeng X, Yan S (2024) Engineering Biodegradable Hollow Silica\/Iron Composite Nanozymes for Breast Tumor Treatment through Activation of the \u201cFerroptosis Storm.\u201d ACS Nano 18:25795\u201325812","journal-title":"ACS Nano"},{"key":"1579_CR146","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1080\/15548627.2023.2165323","volume":"19","author":"Q Xue","year":"2023","unstructured":"Xue Q, Yan D, Chen X, Li X, Kang R, Klionsky DJ, Kroemer G, Chen X, Tang D, Liu J (2023) Copper-dependent autophagic degradation of GPX4 drives ferroptosis. Autophagy 19:1982\u20131996","journal-title":"Autophagy"},{"key":"1579_CR147","doi-asserted-by":"crossref","first-page":"1344971","DOI":"10.3389\/fendo.2024.1344971","volume":"15","author":"R Yan","year":"2024","unstructured":"Yan R, Cai H, Zhou X, Bao G, Bai Z, Ge R-l (2024) Hypoxia-inducible factor-2\u03b1 promotes fibrosis in non-alcoholic fatty liver disease by enhancing glutamine catabolism and inhibiting yes-associated protein phosphorylation in hepatic stellate cells. Front Endocrinol 15:1344971","journal-title":"Front Endocrinol"},{"key":"1579_CR148","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.tcb.2023.07.003","volume":"33","author":"J Yang","year":"2023","unstructured":"Yang J, Lee Y, Hwang CS (2023) The ubiquitin-proteasome system links NADPH metabolism to ferroptosis. Trends Cell Biol 33:1088\u20131103","journal-title":"Trends Cell Biol"},{"key":"1579_CR149","doi-asserted-by":"crossref","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB (2014) 'Regulation of ferroptotic cancer cell death by GPX4'.  J Cell 156: 317\u201331","DOI":"10.1016\/j.cell.2013.12.010"},{"key":"1579_CR150","doi-asserted-by":"crossref","unstructured":"Ye Q, Jiang Y, Wu D, Cai J, Jiang Z, Zhou Z, Liu L, Ling Q, Wang Q, Zhao G (2023) 'Atractylodin alleviates nonalcoholic fatty liver disease by regulating Nrf2-mediated ferroptosis'.\u00a0Heliyon\u00a09(7):e18321","DOI":"10.1016\/j.heliyon.2023.e18321"},{"key":"1579_CR151","doi-asserted-by":"crossref","first-page":"17254","DOI":"10.1039\/C7RA01548H","volume":"7","author":"P Yin","year":"2017","unstructured":"Yin P, Zhang J, Yan L, Yang L, Sun L, Shi L, Ma C, Liu Y (2017) Urolithin C, a gut metabolite of ellagic acid, induces apoptosis in PC12 cells through a mitochondria-mediated pathway. RSC Adv 7:17254\u201317263","journal-title":"RSC Adv"},{"key":"1579_CR152","doi-asserted-by":"crossref","first-page":"112177","DOI":"10.1016\/j.intimp.2024.112177","volume":"134","author":"X Yin","year":"2024","unstructured":"Yin X, Mi Y, Wang X, Li Y, Zhu X, Bukhari I, Wang Q, Zheng P, Xue X, Tang Y (2024a) Exploration and Validation of Ferroptosis-Associated Genes in ADAR1 Deletion-Induced NAFLD through RNA-seq Analysis. Int Immunopharmacol 134:112177","journal-title":"Int Immunopharmacol"},{"key":"1579_CR153","doi-asserted-by":"crossref","first-page":"1431652","DOI":"10.3389\/fendo.2024.1431652","volume":"15","author":"Q Yu","year":"2024","unstructured":"Yu Q, Song L (2024) Unveiling the role of ferroptosis in the progression from NAFLD to NASH: recent advances in mechanistic understanding. Front Endocrinol (Lausanne) 15:1431652","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1579_CR154","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1182\/blood.2019002907","volume":"136","author":"Y Yu","year":"2020","unstructured":"Yu Y, Jiang L, Wang H, Shen Z, Cheng Q, Zhang P, Wang J, Wu Q, Fang X, Duan L, Wang S, Wang K, An P, Shao T, Chung RT, Zheng S, Min J, Wang F (2020) Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis. Blood 136:726\u2013739","journal-title":"Blood"},{"key":"1579_CR155","doi-asserted-by":"crossref","unstructured":"Yuan Y, Zhai Y, Chen J, Xu X, Wang H (2021) 'Kaempferol ameliorates oxygen-glucose deprivation\/reoxygenation-induced neuronal ferroptosis by activating Nrf2\/SLC7A11\/GPX4 Axis'.\u00a0Biomolecules\u00a011:923","DOI":"10.3390\/biom11070923"},{"key":"1579_CR156","doi-asserted-by":"crossref","unstructured":"Yue F, Shi Y, Wu S, Xing L, He D, Wei L, Qiu A, Russell R, Zhang D (2023a) 'Metformin alleviates hepatic iron overload and ferroptosis through AMPK-ferroportin pathway in HFD-induced NAFLD'.\u00a0iScience\u00a026:108560","DOI":"10.1016\/j.isci.2023.108560"},{"key":"1579_CR157","doi-asserted-by":"crossref","first-page":"108560","DOI":"10.1016\/j.isci.2023.108560","volume":"26","author":"F Yue","year":"2023","unstructured":"Yue F, Shi Y, Wu S, Xing L, He D, Wei L, Qiu A, Russell R, Zhang D (2023b) Metformin alleviates hepatic iron overload and ferroptosis through AMPK-ferroportin pathway in HFD-induced NAFLD. Iscience 26:108560","journal-title":"Iscience"},{"key":"1579_CR158","doi-asserted-by":"crossref","first-page":"e202300379","DOI":"10.1002\/anie.202300379","volume":"62","author":"F Zeng","year":"2023","unstructured":"Zeng F, Nijiati S, Tang L, Ye J, Zhou Z, Chen X (2023) Ferroptosis Detection: From Approaches to Applications. Angew Chem Int Ed Engl 62:e202300379","journal-title":"Angew Chem Int Ed Engl"},{"key":"1579_CR159","doi-asserted-by":"crossref","first-page":"1237800","DOI":"10.3389\/fpls.2023.1237800","volume":"14","author":"C Zhang","year":"2023","unstructured":"Zhang C, Wang H, Lyu C, Wang Y, Sun J, Zhang Y, Xiang Z, Guo X, Wang Y, Qin M (2023a) Authenticating the geographic origins of Atractylodes lancea rhizome chemotypes in China through metabolite marker identification. Front Plant Sci 14:1237800","journal-title":"Front Plant Sci"},{"key":"1579_CR160","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s11325-020-02018-z","volume":"24","author":"Li Zhang","year":"2020","unstructured":"Zhang Li, Zhang X, Meng H, Li Y, Han T, Wang C (2020) Obstructive sleep apnea and liver injury in severely obese patients with nonalcoholic fatty liver disease. Sleep and Breathing 24:1515\u20131521","journal-title":"Sleep and Breathing"},{"key":"1579_CR161","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/jcp.29903","volume":"236","author":"J Zhang","year":"2021","unstructured":"Zhang J, Bi J, Ren Y, Du Z, Li T, Wang T, Zhang L, Wang M, Wei S, Lv Y, Wu R (2021) Involvement of GPX4 in irisin\u2019s protection against ischemia reperfusion-induced acute kidney injury. J Cell Physiol 236:931\u2013945","journal-title":"J Cell Physiol"},{"key":"1579_CR162","doi-asserted-by":"crossref","first-page":"1210330","DOI":"10.3389\/fendo.2023.1210330","volume":"14","author":"J Zhang","year":"2023","unstructured":"Zhang J, Zhang Y, Ren Ze, Yan D, Li G (2023b) The role of TRIM family in metabolic associated fatty liver disease. Front Endocrinol 14:1210330","journal-title":"Front Endocrinol"},{"key":"1579_CR163","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.freeradbiomed.2022.10.004","volume":"193","author":"S Zhang","year":"2022","unstructured":"Zhang S, Kang L, Dai X, Chen J, Chen Z, Wang M, Jiang H, Wang X, Bu S, Liu X, Zhang G, Tang H (2022a) Manganese induces tumor cell ferroptosis through type-I IFN dependent inhibition of mitochondrial dihydroorotate dehydrogenase. Free Radic Biol Med 193:202\u2013212","journal-title":"Free Radic Biol Med"},{"key":"1579_CR164","doi-asserted-by":"crossref","first-page":"176341","DOI":"10.1016\/j.ejphar.2024.176341","volume":"966","author":"T Zhang","year":"2024","unstructured":"Zhang T, Wang MY, Wang GD, Lv QY, Huang YQ, Zhang P, Wang W, Zhang Y, Bai YP, Guo LQ (2024a) Metformin improves nonalcoholic fatty liver disease in db\/db mice by inhibiting ferroptosis. Eur J Pharmacol 966:176341","journal-title":"Eur J Pharmacol"},{"key":"1579_CR165","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.freeradbiomed.2022.10.273","volume":"193","author":"W Zhang","year":"2022","unstructured":"Zhang W, Wang J, Liu Z, Zhang L, Jing J, Han L, Gao A (2022b) Iron-dependent ferroptosis participated in benzene-induced anemia of inflammation through IRP1-DHODH-ALOX12 axis. Free Radic Biol Med 193:122\u2013133","journal-title":"Free Radic Biol Med"},{"key":"1579_CR166","doi-asserted-by":"crossref","first-page":"116512","DOI":"10.1016\/j.biopha.2024.116512","volume":"174","author":"W Zhang","year":"2024","unstructured":"Zhang W, Liu Y, Liao Y, Zhu C, Zou Z (2024b) GPX4, ferroptosis, and diseases. Biomed Pharmacother 174:116512","journal-title":"Biomed Pharmacother"},{"key":"1579_CR167","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12986-022-00715-y","volume":"19","author":"X Zhang","year":"2022","unstructured":"Zhang X, Zuo R, Xiao S, Wang L (2022c) Association between iron metabolism and non-alcoholic fatty liver disease: results from the National Health and Nutrition Examination Survey (NHANES 2017\u20132018) and a controlled animal study. Nutr Metab 19:81","journal-title":"Nutr Metab"},{"key":"1579_CR168","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/hep.25746","volume":"56","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Zhang F, Guo X, An P, Tao Y, Wang F (2012) Ferroportin1 in hepatocytes and macrophages is required for the efficient mobilization of body iron stores in mice. Hepatology 56:961\u2013971","journal-title":"Hepatology"},{"key":"1579_CR169","doi-asserted-by":"crossref","first-page":"30","DOI":"10.31083\/j.fbl2901030","volume":"29","author":"S Zhao","year":"2024","unstructured":"Zhao S, Guo Y, Yin X (2024) Autophagy, ferroptosis, apoptosis and pyroptosis in metabolic dysfunction-associated steatotic liver disease. Frontiers in Bioscience-Landmark 29:30","journal-title":"Frontiers in Bioscience-Landmark"},{"key":"1579_CR170","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/cac2.12363","volume":"42","author":"X Zheng","year":"2022","unstructured":"Zheng X, Wang Q, Zhou Y, Zhang D, Geng Y, Hu W, Wu C, Shi Y, Jiang J (2022) N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA. Cancer Commun (Lond) 42:1347\u20131366","journal-title":"Cancer Commun (Lond)"},{"key":"1579_CR171","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40170-021-00250-z","volume":"9","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Tao L, Zhou X, Zuo Z, Gong J, Liu X, Zhou Y, Liu C, Sang N, Liu H, Zou J, Gou K, Yang X, Zhao Y (2021) DHODH and cancer: promising prospects to be explored. Cancer Metab 9:22","journal-title":"Cancer Metab"},{"key":"1579_CR172","doi-asserted-by":"crossref","first-page":"1286449","DOI":"10.3389\/fphar.2023.1286449","volume":"14","author":"B Zhu","year":"2023","unstructured":"Zhu B, Wei Y, Zhang M, Yang S, Tong R, Li W, Long E (2023) Metabolic dysfunction-associated steatotic liver disease: ferroptosis related mechanisms and potential drugs. Front Pharmacol 14:1286449","journal-title":"Front Pharmacol"},{"key":"1579_CR173","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1038\/s41467-019-09277-9","volume":"10","author":"Y Zou","year":"2019","unstructured":"Zou Y, Palte MJ, Deik AA, Li H, Eaton JK, Wang W, Tseng YY, Deasy R, Kost-Alimova M, Dan\u010d\u00edk V, Leshchiner ES, Viswanathan VS, Signoretti S, Choueiri TK, Boehm JS, Wagner BK, Doench JG, Clish CB, Clemons PA, Schreiber SL (2019) A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis. Nat Commun 10:1617","journal-title":"Nat Commun"}],"container-title":["Functional & Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-025-01579-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-025-01579-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-025-01579-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:06:10Z","timestamp":1769155570000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-025-01579-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":173,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1579"],"URL":"https:\/\/doi.org\/10.1007\/s10142-025-01579-0","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"6 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}